Finance

Beta
Lists
MPARK:IST
MLP Saglik Hizmetleri AS
TRY 438.00
-1.79%
(-8.00) 1D
Jun 11, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for MPARK...
Open
TRY 444.75
High
TRY 449.50
Low
TRY 435.75
Mkt. cap
83.66B
Avg. vol.
743.59K
Volume
435.03K
P/E ratio
14.44
52-wk high
TRY 514.00
52-wk low
TRY 299.25
EPS
TRY 30.33
Shares outstanding
191.01M
No. of employees
13K
Open
TRY 444.75
High
TRY 449.50
Low
TRY 435.75
Mkt. cap
83.66B
Avg. vol.
743.59K
Volume
435.03K
P/E ratio
14.44
52-wk high
TRY 514.00
52-wk low
TRY 299.25
EPS
TRY 30.33
Shares outstanding
191.01M
No. of employees
13K
News stories
From sources across the web
Profile
Medical Park Hospitals Group, which has been active in the health care sector since 1995, offers service in various provinces of Turkey with more than 6,000 doctors and employees, 17 hospitals in total. Medical Park is the biggest hospital group in Turkey. The hospital chain was founded by Muharrem Usta, who currently chairs the company. The company owned two hospitals in Istanbul in 2005. In 2006, he initially sold 30% of the company shares to Sancak family. This partnership enabled a rapid growth of the company that led to the establishment of 13 hospitals with 2,000 beds within three years. By the end of 2009, 40% of the company shares were sold to the third biggest US-American global asset management firm The Carlyle Group. With this new partnership, the number of hospitals reached 17 with 2,771 beds in total that placed the company on first rank of its kind in Turkey. In March 2013, it was reported that the Carlyle Group sold its shares at Medical Park to the largest US-American private equity investment firm Texas Pacific Group. Wikipedia
About MLP Saglik Hizmetleri AS
CEOMuharrem Usta
Employees13.1K
Founded1993
Headquarters-
SectorHealth care provider
Websitemlpcare.com
Previous reportsAll values in TRY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TRY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
13.70B
13.06B
15.87B
16.25B
Cost of goods sold
10.16B
9.09B
11.32B
11.78B
Cost of revenue
10.16B
9.09B
11.32B
11.78B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.18B
1.06B
1.38B
1.40B
Operating expense
1.36B
1.39B
801.02M
1.92B
Total operating expenses
11.52B
10.48B
12.12B
13.70B
Operating income
2.18B
2.59B
3.75B
2.55B
Other non operating income
375.59M
235.22M
1.16B
763.32M
EBT including unusual items
1.81B
2.51B
3.24B
2.16B
EBT excluding unusual items
1.82B
2.52B
3.23B
2.22B
Income tax expense
491.76M
680.56M
1.56B
297.02M
Effective tax rate
27.13%
27.09%
48.19%
13.76%
Other operating expenses
174.50M
331.93M
-582.50M
521.21M
Net income
1.22B
1.62B
1.46B
1.67B
Net profit margin
8.88%
12.39%
9.21%
10.26%
Earnings per share
-
-
-
-
Interest and investment income
304.66M
1.51B
-
621.58M
Interest expense
-945.06M
-1.69B
-1.80B
-1.70B
Net interest expenses
-640.40M
-177.17M
-1.80B
-1.08B
Depreciation and amortization charges
-
-
-
-
EBITDA
2.76B
3.38B
6.47B
3.54B
Gain or loss from assets sale
323.00K
583.00K
-1.33B
-6.29M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer